Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2005
10/06/2005US20050220801 Immunopotentiators
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220772 Stem cell screening and transplantation therapy for hiv infection
10/06/2005US20050220767 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
10/06/2005US20050220759 Treating multiple sclerosis by orally administering an excipient and a RANTES polypeptide or a macrophage inflammatory protein; preventing autoimmune and inflammatory diseases and bacterial and viral infections
10/06/2005US20050220757 Chemokine mutants acting as chemokine antagonists
10/06/2005US20050217596 Novel health food and drink containing marine algae
10/06/2005CA2564989A1 Reducing the risk of human and anti-human antibodies through v gene manipulation
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2560922A1 Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/06/2005CA2559458A1 Herbal therapy for the treatment of food allergy
10/06/2005CA2559036A1 9-substituted 8-oxoadenine compound
10/06/2005CA2554535A1 Uses of galectin-2
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1582585A1 Method of selecting novel immunosuppressant
10/05/2005EP1582521A1 Fused furan compound
10/05/2005EP1582216A1 Remedy for pemphigoid
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581532A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581509A2 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
10/05/2005EP1581507A1 Benzamide inhibitors of the p2x7 receptor
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581502A1 Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea
10/05/2005EP1581494A2 Piperidine derivatives useful as ccr5 antagonists
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581238A1 Improvements in or relating to immune functions
10/05/2005EP1581223A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
10/05/2005EP1294393B1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1248654B1 Intra-tumoral administration of il-12 encoding naked nucleic acid molecules
10/05/2005EP1242086B1 Cd45 inhibitors
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1197210B1 Agents inhibiting chronic rejection reactions after organ transplantation
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005EP0914157B1 Anti-tnf antibodies / tnf receptor and methotrexate in the treatment of autoimmune disease
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678606A Novel crystals
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678575A Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678524A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
10/05/2005CN1678350A Remedy
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678347A Antibodies and uses thereof
10/05/2005CN1678338A Method and composition for regulating the activity of regulatory T cells
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678330A Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
10/05/2005CN1678321A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678316A Piperidin-2, 6-dione pamoate salts and their use for the treatment of stress-related affective disorders
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678188A Nucleic acid compositions for stimulating immune responses
10/05/2005CN1676610A Novel penicillium marneffei PPIase II, its coding sequence and use
10/05/2005CN1676609A Novel penicillium marnffei PPIase II, its coding sequence and use
10/05/2005CN1676608A Novel penicillium marneffei ERG1 gene, its coding protein and use
10/05/2005CN1676533A Gecko polysaccharide, and its preparing method and pharmaceutical use
10/05/2005CN1676162A Thymic penta peptide injection liquid
10/05/2005CN1221662C Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/05/2005CN1221551C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221182C Synanthrin products with improved nutritional properties
10/04/2005US6951942 Glucocorticoid-selective anti-inflammatory agents
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951885 Pharmaceutical composition
10/04/2005US6951874 Compounds
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951859 Anticancer agents; diseases associated with signal trans-duction pathways operating through growth factor receptors
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
10/04/2005US6951855 vascular damaging agents
10/04/2005US6951851 Substituted pyrazoles
10/04/2005US6951845 Method for treating allergic lung disease
10/04/2005US6951841 Bioavailability; side effect reduction
10/04/2005US6951756 Closure of bacterial ghost
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951641 administering a dimeric nonionic X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering allergic conjunctivtis and allergic rhinitis
10/04/2005CA2104877C Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
09/2005
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005089788A1 Medicine for cancer therapy
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005018556A3 Hydroxylamine substituted imidazo-containing compounds
09/29/2005WO2005003335A9 Rapamycin resistant t cells and therapeutic uses thereof
09/29/2005US20050216958 Fucosyltransferase knock-out host cell for use as bioreactors in production of preferentially modified glycoproteins
1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 1172